Research & Development

Caris Life Sciences™ is developing the next generation of individualized diagnostic tests to provide patients with more detailed information at ever earlier stages of their disease. These diagnostic technologies will allow physicians to provide patients with precise and effective medical interventions with fewer side-effects.

The Caris research team is performing fundamental research on new types of biomarkers that will enable early detection of diseases with an emphasis on non-invasive methods. These methods reduce the need for painful, risky and expensive biopsies and facilitate longitudinal studies to monitor disease status and responsiveness to therapy.

Caris is partnering with leading universities and research institutions to bring cutting-edge diagnostic technologies to patients. The company's expertise in commercializing molecular profiling tests, combined with trusted relationships with thousands of physicians across the nation, makes Caris the partner of choice for molecular diagnostic testing and development.